Skip to main content
. 2019 Sep 3;11(17):6839–6850. doi: 10.18632/aging.102215

Table 4. Unadjusted and adjusted regression analysis for clinical outcomes in IVT patients.

OR (95%CI) for END P OR (95%CI) for poor outcome at 3 months P HR (95%CI) for mortality at 3 months P
Unadjusted model
 SHyper vs Euthyroidism 3.26 (1.75–6.06) 0.001 2.51 (1.36–4.63) 0.003 3.98 (2.24–7.43) 0.001
 SHypo vs Euthyroidism 0.58 (0.27–1.25) 0.164 0.75 (0.48–1.17) 0.207 0.51 (0.18–1.44) 0.199
Model 1
 SHyper vs Euthyroidism 3.96 (2.06–7.68) 0.001 3.14 (1.66–5.92) 0.001 3.92 (2.13–7.24) 0.001
 SHypo vs Euthyroidism 0.56 (0.25–1.23) 0.146 0.72 (0.46–1.15) 0.167 0.48 (0.17–1.36) 0.166
Model 2
 SHyper vs Euthyroidism 4.35 (1.86–9.68) 0.003 3.24 (1.43–7.33) 0.005 2.78 (1.55–5.36) 0.003
 SHypo vs Euthyroidism 0.78 (0.30–2.01) 0.601 0.58 (0.30–1.12) 0.104 0.47 (0.14–1.75) 0.225

Abbreviations: CI: confidence interval; END: Early neurological deterioration; HR: hazard ratio; OR: odd ratio.